Linking lipids to Alzheimer's disease: cholesterol and beyond

G Di Paolo, TW Kim - Nature Reviews Neuroscience, 2011 - nature.com
Lipid-mediated signalling regulates a plethora of physiological processes, including crucial
aspects of brain function. In addition, dysregulation of lipid pathways has been implicated in …

The ketogenic diet as a potential treatment and prevention strategy for Alzheimer's disease

GM Broom, IC Shaw, JJ Rucklidge - Nutrition, 2019 - Elsevier
The prevalence of Alzheimer's disease, a chronic neurodegenerative condition, is
increasing as is the need for effective treatments and preventions. The underlying pathology …

The use of PET in Alzheimer disease

A Nordberg, JO Rinne, A Kadir… - Nature Reviews …, 2010 - nature.com
In Alzheimer disease (AD), which is the most common cause of dementia, the underlying
disease pathology most probably precedes the onset of cognitive symptoms by many years …

Oxidative Stress and β-Amyloid Protein in Alzheimer's Disease

Z Cai, B Zhao, A Ratka - Neuromolecular medicine, 2011 - Springer
Oxidative stress has been proposed to be an important factor in the pathogenesis of
Alzheimer's disease (AD) and contributed to β-amyloid (A β) generation. Interaction between …

Clusterin: a forgotten player in Alzheimer's disease

T Nuutinen, T Suuronen, A Kauppinen… - Brain research reviews, 2009 - Elsevier
Clusterin, also known as apolipoprotein J, is a versatile chaperone molecule which contains
several amphipathic and coiled-coil α-helices, typical characteristics of small heat shock …

MiR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression

J Kim, H Yoon, CM Ramírez, SM Lee, HS Hoe… - Experimental …, 2012 - Elsevier
ATP-binding cassette transporter A1 (ABCA1) is a cholesterol transporter that transfers
excess cellular cholesterol onto lipid-poor apolipoproteins. Given its critical role in …

Direct binding of cholesterol to the amyloid precursor protein: An important interaction in lipid–Alzheimer's disease relationships?

AJ Beel, M Sakakura, PJ Barrett, CR Sanders - Biochimica et Biophysica …, 2010 - Elsevier
It is generally believed that cholesterol homoeostasis in the brain is both linked to and
impacted by Alzheimer's disease (AD). For example, elevated levels of cholesterol in …

[HTML][HTML] Neurovascular alterations in vascular dementia: emphasis on risk factors

S Lecordier, D Manrique-Castano… - Frontiers in aging …, 2021 - frontiersin.org
Vascular dementia (VaD) constitutes the second most prevalent cause of dementia in the
world after Alzheimer's disease (AD). VaD regroups heterogeneous neurological conditions …

ApoE and neurodegenerative diseases in aging

Y Yin, Z Wang - Aging and Aging-related diseases: Mechanisms and …, 2018 - Springer
Age and apolipoprotein E (ApoE) are the mightiest risk factors for dementia and
cardiovascular diseases, but the underlying mechanisms remain unclear. In human, ApoE …

Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review

KL Rasmussen - Atherosclerosis, 2016 - Elsevier
Dementia is one of the major causes of disability in later life, and ischemic heart disease is a
leading cause of morbidity and mortality. Apolipoprotein E (apoE) plays a pivotal role in …